Eric Engleman, Ph.D.
Eric A. Engleman, Ph.D.
|Personal Statement||I study the neurobiology of alcoholism using alcohol-preferring rodent lines. My current focus is using neurochemical and pharmacological techniques to study (1) the differences in dopamine neurotransmission in specific central nervous system sites and circuits that are associated with the selection for alcohol drinking and (2) the neuroadaptations in these circuits that result from alcohol drinking and subsequent deprivation which may be associated with the initiation or maintenance of alcohol drinking and/or relapse.|
|Education||Undergraduate: Indiana University
Graduate School: Indiana University School of Medicine
Postdoctoral Fellowship: Eli Lilly and Company
|Current Academic Interests||
Teaching: Involved in teaching undergraduate students in the School of Science, graduate students in the Psychobiology and Neuroscience programs on campus, and general psychiatry residents.
Research: Primary research focus is using animal models to study the neurobiology of alcohol and drug abuse.
|Recent Publications||E.A Engleman, Z.A. Rodd, R.L. Bell, and J.M. Murphy. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS and Neurological Disorders – Drug Targets, 7: 455-467, 2008.
Z. Ding, W. Liu, E.A. Engleman, Z.A. Rodd, W.J. McBride. Differential dopamine D2 and GABAA receptor regulation of dopamine neurons between the anterior and posterior ventral tegmental area of the Wistar rat. Pharmacology Biochemistry and Behavior. 92(3):404-12, 2009.
E.A. Engleman, Z. Ding, S.M. Oster, J.E. Toalston, R.L. Bell, J.M. Murphy, W.J. McBride, Z.A. Rodd. Ethanol is Self-Administered into the Nucleus Accumbens Shell, but not the Core: Evidence of Genetic Sensitivity. Alcoholism: Clinical and Experimental Research, in press.